These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38514281)

  • 1. Comparison of enoxaparin 40 mg versus 60 mg dosage for venous thromboprophylaxis in patients undergoing bariatric surgery: A randomized controlled trial.
    Kongsawat K; Chaivanijchaya K; Pakul F; Joradol S; Kachornvitaya P; Boonchaya-Anant P; Udomsawaengsup S
    Asian J Surg; 2024 Jul; 47(7):2985-2990. PubMed ID: 38514281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial.
    Steele KE; Canner J; Prokopowicz G; Verde F; Beselman A; Wyse R; Chen J; Streiff M; Magnuson T; Lidor A; Schweitzer M
    Surg Obes Relat Dis; 2015; 11(3):672-83. PubMed ID: 25620436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Use of Enoxaparin in Adolescents During Bariatric Surgery-a Prospective Clinical Study.
    Vaughns JD; Ziesenitz VC; Williams EF; Nadler EP; Mikus G; van den Anker J
    Obes Surg; 2020 Jan; 30(1):63-68. PubMed ID: 31463801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once versus twice daily injection of enoxaparin for thromboprophylaxis in bariatric surgery: effects on antifactor Xa activity and procoagulant microparticles. A randomized controlled study.
    Steib A; Degirmenci SE; Junke E; Asehnoune K; Figier M; Pericard C; Rohr S; Letessier E; Brunaud L; Vix M; Zobairi F; Grunebaum L; Toti F
    Surg Obes Relat Dis; 2016; 12(3):613-621. PubMed ID: 26686309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fixed-dose enoxaparin after bariatric surgery: the influence of body weight on peak anti-Xa levels.
    Celik F; Huitema AD; Hooijberg JH; van de Laar AW; Brandjes DP; Gerdes VE
    Obes Surg; 2015 Apr; 25(4):628-34. PubMed ID: 25223871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two low-molecular-weight heparin dosing regimens for patients undergoing laparoscopic bariatric surgery.
    Simone EP; Madan AK; Tichansky DS; Kuhl DA; Lee MD
    Surg Endosc; 2008 Nov; 22(11):2392-5. PubMed ID: 18594915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Enoxaparin in Obese Adolescents During Bariatric Surgery--a Pilot Study.
    Mushtaq A; Vaughns JD; Ziesenitz VC; Nadler EP; van den Anker JN
    Obes Surg; 2015 Oct; 25(10):1869-74. PubMed ID: 25716128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma.
    Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Padiadpu AB; Martin AG; Lama G; Lineen EB; Namias N; Schulman CI; Proctor KG
    JAMA Surg; 2018 Feb; 153(2):144-149. PubMed ID: 29071333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoxaparin dosing after cesarean delivery in morbidly obese women.
    Overcash RT; Somers AT; LaCoursiere DY
    Obstet Gynecol; 2015 Jun; 125(6):1371-1376. PubMed ID: 26000508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma.
    Ko A; Harada MY; Barmparas G; Chung K; Mason R; Yim DA; Dhillon N; Margulies DR; Gewertz BL; Ley EJ
    JAMA Surg; 2016 Nov; 151(11):1006-1013. PubMed ID: 27383732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients.
    Ludwig KP; Simons HJ; Mone M; Barton RG; Kimball EJ
    Ann Pharmacother; 2011 Nov; 45(11):1356-62. PubMed ID: 22009998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supraprophylactic Anti-Factor Xa Levels Are Associated with Major Bleeding in Neurosurgery Patients Receiving Prophylactic Enoxaparin.
    May CC; Cua S; Smetana KS; Powers CJ
    World Neurosurg; 2022 Jan; 157():e357-e363. PubMed ID: 34655821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twice-Daily Enoxaparin among Plastic Surgery Inpatients: An Examination of Pharmacodynamics, 90-Day Venous Thromboembolism, and 90-Day Bleeding.
    Pannucci CJ; Fleming KI; Momeni A; Prazak AM; Agarwal J; Rockwell WB
    Plast Reconstr Surg; 2018 Jun; 141(6):1580-1590. PubMed ID: 29608533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-center Experience with Venous Thromboembolism Prophylaxis for Obese Burn Patients.
    McKinzie BP; Nizamani R; Jones S; King B; Williams FN
    J Burn Care Res; 2021 May; 42(3):365-368. PubMed ID: 33674883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic Enoxaparin Adjusted by Anti-Factor Xa Peak Levels Compared with Recommended Thromboprophylaxis and Rates of Clinically Evident Venous Thromboembolism in Surgical Oncology Patients.
    Kramme K; Sarraf P; Munene G
    J Am Coll Surg; 2020 Mar; 230(3):314-321. PubMed ID: 31843692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended use of bemiparin as thromboprophylaxis during bariatric surgery: results of anti-factor Xa activity measurements.
    Muñoz-Atienza V; Gil-Rendo A; Amo-Salas M; Núñez-Guerrero P; Martín-Fernández J
    Surg Obes Relat Dis; 2018 Mar; 14(3):354-360. PubMed ID: 29361459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study.
    Hamad GG; Choban PS
    Obes Surg; 2005; 15(10):1368-74. PubMed ID: 16354513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Body Mass Index-Based Prophylactic Enoxaparin Dosing in Bariatric Surgery Patients.
    Chang CK; Higgins RM; Rein L; Peppard WJ; Herrmann DJ; Kindel T
    J Surg Res; 2023 Jul; 287():168-175. PubMed ID: 36933548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Anti-Factor Xa Levels of Patients Undergoing Colorectal Surgery Given Once-Daily Enoxaparin Prophylaxis: A Clinical Study Examining Enoxaparin Pharmacokinetics.
    Pannucci CJ; Fleming KI; Bertolaccini CB; Prazak AM; Huang LC; Pickron TB
    JAMA Surg; 2019 Aug; 154(8):697-704. PubMed ID: 31116389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-factor Xa levels in patients undergoing laparoscopic sleeve gastrectomy: 2 different dosing regimens of enoxaparin.
    Gelikas S; Eldar SM; Lahat G
    Surg Obes Relat Dis; 2017 Oct; 13(10):1753-1759. PubMed ID: 28918992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.